Lifeward

Lifeward OCF/Debt

The Operating Cash Flow to Debt Ratio of Lifeward (LFWD) as of Nov 2, 2026 is -383.54 %. In the previous year, Operating Cash Flow to Debt Ratio was -2,467.95 % — a change of -84.46% (higher).

OCF/Debt

-383.54 %

YoY

-84.46%

Last updated:

Operating Cash Flow to Debt Ratio of Lifeward is 2025 -383.54 % . Operating Cash Flow to Debt Ratio of Lifeward was 2024 -2,467.95 % . It decreases by -84.46% higher compared to the previous year.

The Lifeward OCF/Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

OCF/Debt
Date
OCF/Debt
Jan 1, 2018
-170.07 USD
Jan 1, 2019
-166.14 USD
Jan 1, 2020
-795.26 USD
Jan 1, 2021
-1,083.00 USD
Jan 1, 2022
-1,994.54 USD
Jan 1, 2023
-1,086.02 USD
Jan 1, 2024
-2,467.95 USD
Jan 1, 2025
-383.54 USD
The Lifeward OCF/Debt history
YEAROCF/DebtYoY
-383.54 %-84.46%
-2,467.95 %+127.25%
-1,086.02 %-45.55%
-1,994.54 %+84.17%
-1,083.00 %+36.18%
-795.26 %+378.66%
-166.14 %-2.31%
-170.07 %+16.05%
-146.55 %-4.14%
-152.87 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Lifeward Stock analysis

What does Lifeward do? Rewalk Robotics Ltd is a publicly traded company specializing in the development and manufacture of exoskeletons that enable individuals with spinal injuries or paralysis to regain mobility. It was founded in 2001 and is based in Marlborough, Massachusetts. The company's goal is to provide individuals with mobility impairments the opportunity for greater freedom of movement and improved quality of life. Rewalk Robotics has launched various products in the field of rehabilitation and industrial applications, and it continues to research and develop new applications for its technology. The exoskeletons use a combination of motors, sensors, and control systems to allow users to stand, walk, and even climb stairs. In addition to medical applications, Rewalk Robotics also provides exoskeletons for industrial use, enhancing worker safety and productivity. The company is actively involved in research and development to expand the therapeutic possibilities of exoskeletons for neurologic conditions such as stroke and Parkinson's disease. Rewalk Robotics is dedicated to innovation and technology, aiming to improve the lives of millions worldwide by providing greater mobility and autonomy. Lifeward is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Lifeward stock

Operating Cash Flow to Debt Ratio of Lifeward is -383.54 % in 2025.

Operating Cash Flow to Debt Ratio of Lifeward changed from -2,467.95 % to -383.54 %, representing a -84.46% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow to Debt Ratio Lifeward since 2006 – with annual values, charts, and detailed analysis.

OCF/Debt measures what percentage of total debt can be covered by annual operating cash flow. Higher ratios indicate stronger debt repayment capacity.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Cash Flow to Debt Ratio's Lifeward with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Lifeward

All Key Metrics — Lifeward